UBS Group’s Virtus LifeSci Biotech Clinical Trials ETF BBC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $217K | Buy |
+11,216
| New | +$217K | ﹤0.01% | 5430 |
|
|
2025
Q1 | – | Sell |
-168
| Closed | -$4.02K | – | 8888 |
|
|
2024
Q4 | $4.02K | Buy |
+168
| New | +$4.02K | ﹤0.01% | 7555 |
|
|
2024
Q2 | – | Sell |
-698
| Closed | -$20.3K | – | 8327 |
|
|
2024
Q1 | $20.3K | Sell |
698
-751
| -52% | -$21.9K | ﹤0.01% | 5754 |
|
|
2023
Q4 | $35.4K | Sell |
1,449
-81
| -5% | -$1.98K | ﹤0.01% | 5543 |
|
|
2023
Q3 | $30K | Buy |
1,530
+1,036
| +210% | +$20.3K | ﹤0.01% | 5453 |
|
|
2023
Q2 | $11.8K | Buy |
+494
| New | +$11.8K | ﹤0.01% | 6014 |
|
|
2023
Q1 | – | Sell |
-3,290
| Closed | -$82.2K | – | 8470 |
|
|
2022
Q4 | $82.2K | Buy |
3,290
+2,313
| +237% | +$57.8K | ﹤0.01% | 5149 |
|
|
2022
Q3 | $24K | Buy |
977
+648
| +197% | +$15.9K | ﹤0.01% | 6044 |
|
|
2022
Q2 | $7K | Sell |
329
-1,355
| -80% | -$28.8K | ﹤0.01% | 7410 |
|
|
2022
Q1 | $47K | Sell |
1,684
-622
| -27% | -$17.4K | ﹤0.01% | 5532 |
|
|
2021
Q4 | $89K | Buy |
2,306
+2,182
| +1,760% | +$84.2K | ﹤0.01% | 5337 |
|
|
2021
Q3 | $6K | Sell |
124
-210
| -63% | -$10.2K | ﹤0.01% | 7258 |
|
|
2021
Q2 | $17K | Sell |
334
-2,419
| -88% | -$123K | ﹤0.01% | 6404 |
|
|
2021
Q1 | $141K | Buy |
+2,753
| New | +$141K | ﹤0.01% | 4722 |
|
|
2020
Q4 | – | Sell |
-701
| Closed | -$27K | – | 7332 |
|
|
2020
Q3 | $27K | Buy |
701
+615
| +715% | +$23.7K | ﹤0.01% | 5208 |
|
|
2020
Q2 | $4K | Sell |
86
-817
| -90% | -$38K | ﹤0.01% | 6572 |
|
|
2020
Q1 | $26K | Buy |
+903
| New | +$26K | ﹤0.01% | 5420 |
|
|
2019
Q4 | – | Sell |
-233
| Closed | -$6K | – | 7010 |
|
|
2019
Q3 | $6K | Sell |
233
-1,055
| -82% | -$27.2K | ﹤0.01% | 6423 |
|
|
2019
Q2 | $37K | Buy |
1,288
+1,205
| +1,452% | +$34.6K | ﹤0.01% | 5295 |
|
|
2019
Q1 | $2K | Sell |
83
-1,927
| -96% | -$46.4K | ﹤0.01% | 6581 |
|
|
2018
Q4 | $47K | Sell |
2,010
-922
| -31% | -$21.6K | ﹤0.01% | 5233 |
|
|
2018
Q3 | $101K | Buy |
2,932
+1,862
| +174% | +$64.1K | ﹤0.01% | 4723 |
|
|
2018
Q2 | $35K | Buy |
1,070
+251
| +31% | +$8.21K | ﹤0.01% | 5364 |
|
|
2018
Q1 | $27K | Buy |
819
+103
| +14% | +$3.4K | ﹤0.01% | 5310 |
|
|
2017
Q4 | $20K | Buy |
+716
| New | +$20K | ﹤0.01% | 5588 |
|
|
2017
Q3 | – | Sell |
-36
| Closed | -$1K | – | 6763 |
|
|
2017
Q2 | $1K | Sell |
36
-893
| -96% | -$24.8K | ﹤0.01% | 6521 |
|
|
2017
Q1 | $22K | Sell |
929
-983
| -51% | -$23.3K | ﹤0.01% | 5155 |
|
|
2016
Q4 | $35K | Buy |
+1,912
| New | +$35K | ﹤0.01% | 5183 |
|
|
2016
Q2 | – | Sell |
-458
| Closed | -$9K | – | 6774 |
|
|
2016
Q1 | $9K | Sell |
458
-1,405
| -75% | -$27.6K | ﹤0.01% | 5858 |
|
|
2015
Q4 | $54K | Buy |
1,863
+1,786
| +2,319% | +$51.8K | ﹤0.01% | 4686 |
|
|
2015
Q3 | $2K | Sell |
77
-781
| -91% | -$20.3K | ﹤0.01% | 6565 |
|
|
2015
Q2 | $31K | Buy |
858
+624
| +267% | +$22.5K | ﹤0.01% | 5135 |
|
|
2015
Q1 | $8K | Buy |
+234
| New | +$8K | ﹤0.01% | 5978 |
|